Hostname: page-component-745bb68f8f-f46jp Total loading time: 0 Render date: 2025-02-11T03:08:44.118Z Has data issue: false hasContentIssue false
  • English
  • Français

Maintenance Treatment of Erectile Impotence by Cavernosal Unstriated Muscle Relaxant Injection

Published online by Cambridge University Press:  29 January 2018

G. S. Brindley
G. S. Brindley*
Affiliation:
Institute of Psychiatry, De Crespigny Park, London SE5 8AF
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Intracavernosal injection of phenoxybenzamine or papaverine has been tried on 127 men suffering from erectile impotence. In 113 of them it caused an erection which should have sufficed for coitus. Seventy-three men have used such injections, given at home by themselves or their wives, fortnightly or less often, to make coitus possible after each injection; 54 of them still do so.

Type
Papers
Information
The British Journal of Psychiatry , Volume 149 , Issue 2 , August 1986 , pp. 210 - 215
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

References

Brindley, G. S. (1981) Electroejaculation: its technique, neurological implications and uses. Journal of Neurology, Neurosurgery and Psychiatry, 44, 9–18.Google Scholar
Brindley, G. S. (1983) Cavernosal alpha-blockade: a new treatment for investigating and treating erectile impotence. British Journal of Psychiatry, 143, 332–337.CrossRefGoogle ScholarPubMed
Brindley, G. S. (1984) New treatment for priapism. The Lancet, ii, 220–221.Google Scholar
Brindley, G. S. (1986) Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis. British Journal of Pharmacology, 87, 495–500.CrossRefGoogle ScholarPubMed
Fund, A. C. (1984) Cavernosal alpha-blockade: a warning. British Journal of Psychiatry, 144, 329–330.Google Scholar
Gillan, P. W. & Brindley, G. S. (1979) Vaginal and pelvic floor responses to sexual stimulation. Psychophysiology, 16, 471–481.CrossRefGoogle ScholarPubMed
Stackl, W. & Bucher, A. (1984) Intracavernous injection of phenoxybenzamine for erectile dysfunction. 1st World Meeting on Impotence, Paris, June 1984.Google Scholar
Virag, R. (1982) Intracavernous injection of papaverine for erectile failure. The Lancet, ii, 938.Google Scholar
Virag, R. & Virag, H (1983) L'épreuve a la papavérine intracaverneuse dans l'etude de l'impuissance. Journal des Maladies Vasculaires, 8, 293–295.Google Scholar
Virag, R., Frydman, D., Legman, M. & Virag, H. (1984) Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure. Angiology, 25, 79–87.Google Scholar
Virag, R. (1985a) Du bon usage de la papaverine intracavemeuse et d'autres drogues vasoactives dans le traitement de l'impuissance. Gazette Medicale, 92, 19–24.Google Scholar
Virag, R. (1985b) About pharmacologically induced prolonged erection. The Lancet, i, 519–520.Google Scholar
Zorgniotti, A. W. & Lefleur, R. S. (1985) Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. Journal of Urology, 133, 39–41.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.